Abstract: The present disclosure relates to a functional composition for the prevention, amelioration or treatment of obesity or lipid-related metabolic disorders, which comprises a steroid sulfatase inhibitor as an active ingredient.

Abstract: A steroid sulfatase inhibitor provided by the present invention is a safe substance without toxicity and adverse effects, has inhibitory activity against various viruses, and thus is capable of effectively preventing, ameliorating, or treating viral infections or diseases caused by viral infections.

Abstract: The present disclosure relates to a functional composition for the prevention, amelioration or treatment of obesity or lipid-related metabolic disorders, which comprises a steroid sulfatase inhibitor as an active ingredient.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating a bone-related disease; and the pharmaceutical composition is very effective in preventing or treating bone-related diseases in that it not only promotes differentiation of preosteoblast cells into osteoblasts to induce production of mineralized nodules, but also, at the same time, inhibits differentiation of bone marrow cells into osteoclasts and the function of osteoclasts so that bone homeostasis is effectively regulated.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating a bone-related disease; and the pharmaceutical composition is very effective in preventing or treating bone-related diseases in that it not only promotes differentiation of preosteoblast cells into osteoblasts to induce production of mineralized nodules, but also, at the same time, inhibits differentiation of bone marrow cells into osteoclasts and the function of osteoclasts so that bone homeostasis is effectively regulated.

Abstract: The present disclosure relates to a functional composition for the prevention, amelioration or treatment of obesity or lipid-related metabolic disorders, which comprises a steroid sulfatase inhibitor as an active ingredient.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating a bone-related disease; and the pharmaceutical composition is very effective in preventing or treating bone-related diseases in that it not only promotes differentiation of preosteoblast cells into osteoblasts to induce production of mineralized nodules, but also, at the same time, inhibits differentiation of bone marrow cells into osteoclasts and the function of osteoclasts so that bone homeostasis is effectively regulated.

Abstract: A black box apparatus and apparatus for supporting the reconfiguration of a smart grid system. The apparatus includes a monitoring unit, an information collection unit, and an information storage unit. The monitoring unit generates function information relate to a system call when the system call is invoked by an application program inside the system. The information collection unit collects system call information including the parameter values of a corresponding function using the generated function information. The information storage unit stores the collected system call information in a nonvolatile memory area of the system.

Abstract: The present invention relates to an apparatus and method for collecting network data traffic. The apparatus for collecting network data traffic includes a graph creation unit, an initialization unit, an edge selection unit, a reconstruction unit, an algorithm application unit and a traffic collection route provision unit. The reconstruction unit converts the selected edge into an inactive edge and connects the inactive edge to two nodes, so that the reconstruction unit reconstructs the tree structure. The algorithm application unit applies a minimal spanning tree algorithm to the reconstructed tree structure. The traffic collection route provision unit eliminates a leaf node and a leaf edge from the tree structure to which the minimal spanning tree algorithm has been applied, and generates a monitoring tree for providing a traffic collection route minimizing a total weight of the edges.

Abstract: Provided is a method for responding a distributed denial of service (DDoS) attack using deterministic pushback scheme. In the method, all of packets outbound from an edge router of a predetermined network system to the other network system are marked with own IP address in order to enable a victim system to confirm an IP address of an attack source edge router for DDoS attack packets. Then, IP address information of an attack source edge router is obtained by reassembling an IP address of detected DDoS attack packets at a victim system that detects DDoS attack. A deterministic pushback message is received at an attack source edge router if a victim system transmits a deterministic pushback message to the attack source edge router, information of the attack source edge router is confirmed, and corresponding attack packets are filtered.